NorthStrive Fund II LP 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-10 3:47 pm Sale | 2025-12-09 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | NorthStrive Fund II LP | 0 0.000% | -29,920 (Position Closed) | Filing |
| 2025-12-05 5:40 pm Purchase | 2025-12-03 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | NorthStrive Fund II LP | 29,920 5.010% | 29,920 (New Position) | Filing |